Frankfurt-am-Main, Germany

Martin Michaelis

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 4.3

ph-index = 4

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2008-2016

Loading Chart...
Loading Chart...
10 patents (USPTO):

Title: Inventor Spotlight: Martin Michaelis

Introduction

Martin Michaelis, a notable inventor based in Frankfurt-am-Main, Germany, has made significant contributions to the field of pharmaceuticals and pain management. With a portfolio of 10 patents, his innovative approaches have paved the way for advancements in therapeutic methods and chemical compounds.

Latest Patents

Among his most recent patents, Michaelis has developed a "Method for alleviating pain using sphingosine-1-phosphate and related compounds, and assays for identifying such compounds." This groundbreaking method involves administering sphingosine-1-phosphate along with its functional fragments and derivatives to effectively manage pain. Additionally, he holds a patent for "Condensation products based on bicyclic or polycyclic aromatics or heteroaromatics," which relates to a condensation product obtainable through specific chemical reactions.

Career Highlights

Throughout his career, Martin Michaelis has worked with leading companies in the pharmaceutical industry, including Sanofi and Sanofi-Aventis Deutschland GmbH. His work at these organizations has contributed to the development of innovative solutions in pain relief and medicinal chemistry.

Collaborations

Michaelis has collaborated with renowned professionals in the field, including Gerd Geisslinger and Karl Rudolphi. These partnerships have enabled the fusion of expertise and resources, furthering the research and development of impactful pharmaceutical innovations.

Conclusion

With a focus on pain management and chemical innovations, Martin Michaelis continues to be a valuable contributor to the field of pharmaceuticals. His patents and collaborations highlight the importance of innovative research in enhancing therapeutic options for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…